A new study suggests the shingles vaccine may reduce the risk of heart disease for up to eight years post-vaccination. A ...

The shingles vaccine may not only prevent shingles, but also lower your risk of heart disease and stroke, according to a new study.

GlaxoSmithKline places its shingles vaccine Shingrix among its top prospects, with peak sales potential of almost $6 billion. Now, Pfizer and BioNTech are joining forces to try to grab a slice of ...

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.